INGLIS TIFFANY EUL DAVIS (Chief Medical Officer) sold 8.8% of their position (8.02K shares) of SERA PROGNOSTICS, INC. on the open market
Open‑market sale worth $16.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/13/2026ACC: 0002091798-26-000010
Officer· Chief Medical Officer
Since Mar 2026
-8.02K
Net shares
Net seller
$16.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.02K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−8.02K
Price / share
$2.03
Trade value
$16.29K
% of position
8.8%
10/12/2026
91.59K→83.56K
Total
Net shares
−8.02K
Net value
-$16.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 10/12/2026 | S · Sale | −8.02K | $2.03 | $16.29K | 8.8% | 91.59K | 83.56K |
| Total | −8.02K | -$16.29K | ||||||
Derivative Transactions0
No derivative transactions reported